HistoAtlas: A Pan-Cancer Morphology Atlas Linking Histomics to Molecular Programs and Clinical Outcomes
HistoAtlas has been introduced as a comprehensive pan-cancer computational atlas that extracts 38 histomic features from 6,745 diagnostic H&E slides across 21 TCGA cancer types, linking these features to survival rates, gene expression, somatic mutations, and immune subtypes.
WPN Brief
- What Happened
HistoAtlas has been introduced as a comprehensive pan-cancer computational atlas that extracts 38 histomic features from 6,745 diagnostic H&E slides across 21 TCGA cancer types, linking these features to survival rates, gene expression, somatic mutations, and immune subtypes.
- Why It Matters
This development is significant as it enables systematic biomarker discovery from routine H&E slides without the need for specialized staining or sequencing, potentially enhancing diagnostic accuracy and treatment strategies in oncology.
- The Bigger Picture
The emergence of HistoAtlas aligns with ongoing advancements in computational pathology, emphasizing the importance of integrating histomics with molecular data to improve patient outcomes and facilitate early diagnosis through innovative methodologies like the Multitask and Multimodal Supervised Framework and efficient whole slide image analysis.